CAR Macrophages Tackle Challenges in Solid Cancer Treatment
CAR Macrophages Tackle Challenges in Solid Cancer Treatment The advent of chimeric antigen receptor T cell technology has revolutionized the treatment of blood, or “liquid,” cancers. But solid tumors have largely resisted this type of immunotherapy. To overcome this obstacle, some researchers have started adding CARs to immune cells other than T cells. On March […]
Read More